INS and type 1 diabetes mellitus: It should be noted that as the addition of non‐insulin drugs in type 1 diabetes in humans is a promising strategy for improving glycaemic control in patients with diabetes (Baștan & Börkü, 2010; Frandsen et al., 2016; Wright & Hirsch, 2019), it may also be a possibility in dogs.